Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON36940Phase 4Active, not recruiting
Phase 4, randomised, open-label trial of amlodipine in hypertension (HTN) (2 arms), sponsored by Erasmus MC. Primary endpoints: Cmax, tmax and 2 more. Started Mar 2013; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON36940.